BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 26, 2016
View Archived Issues
New drug for GI radiation injury
Read More
ABLS II completes drug candidate feasibility program
Read More
CD31 expression on CD4 T cells correlated with respiratory disease in premature infants
Read More
P2Y6 receptor identified as a therapeutic target for asthma
Read More
Monoclonal antibody targets gastric inhibitory polypeptide to treat obesity
Read More
Acad10 gene knockout mice are a potential model of diabetes
Read More
Lundbeck patents BACE1 inhibitors
Read More
Bristol-Myers Squibb divulges IDO inhibitors to treat cancer
Read More
Lysosomal Therapeutics announces glucosylceramidase activators
Read More
Amorsa Therapeutics presents NMDA receptor antagonists
Read More
Eli Lilly introduces drug conjugates for bone disorders
Read More
Seed funding for Global Antibiotic Research and Development partnership
Read More
FDA will not meet PDUFA date for Sarepta's eteplirsen NDA
Read More
Eisai launches Fycompa tablets in Japan
Read More
Tetragenetics begins partnership with Theranyx
Read More
FDA grants fast track status to Novavax's RSV F vaccine
Read More
Alkermes begins phase I trial of ALKS-4230
Read More
Successful phase II results for solithromycin in community-acquired bacterial pneumonia
Read More
Kamada's alpha1-antitrypsin is available in Europe via myTomorrows early access platform
Read More
FDA advisory committee recommends approval of insulin glargine/lixisenatide
Read More
Juno Therapeutics signs intent to collaborate with Seattle Children's
Read More
SEATTLE study of emixustat in geographic atrophy fails to meet primary endpoint
Read More
BioXcel and Alnylam enter strategic collaboration to discover novel RNAi therapeutics
Read More
Michael J. Fox Foundation for Parkinson's Research announces new funding and partnership
Read More
FDA grants orphan drug designation to Viamet's VT-1598
Read More